Fortress Investment Group LLC – Trademark Portfolio
Entity Type: 16
Fortress Investment Group LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 11 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 2 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include E, DRAWBRIDGE, EUROCASTLE, DRAWBRIDGE GLOBAL MACRO FUND, and DRAWBRIDGE SPECIAL OPPORTUNITIES FUND. The owner is based in New York, NY.
1345 Avenue of the Americas
New York, NY 10105
Showing of trademarks Trademarks
Trademark Classifications
Fortress Investment Group LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Fortress Investment Group LLC have?
Fortress Investment Group LLC has 11 U.S. trademarks filed with the USPTO. Of these, 7 registered, 4 abandoned.
What trademark classes does Fortress Investment Group LLC file in?
Fortress Investment Group LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 37 (Building & Construction). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Fortress Investment Group LLC's most well-known trademarks?
Fortress Investment Group LLC's registered trademark portfolio includes well-known marks such as E, DRAWBRIDGE, EUROCASTLE, DRAWBRIDGE GLOBAL MACRO FUND, and DRAWBRIDGE SPECIAL OPPORTUNITIES FUND. These are among 7 currently registered trademarks in the portfolio.
What is Fortress Investment Group LLC's trademark registration success rate?
Fortress Investment Group LLC has a 64% trademark registration rate, with 7 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.